Creative Medical Technology Holdings Inc (CELZ)

[hann-d]

A clinical trial is VERY expensive so I doubt there will be another one.
The efficacy of a stem cell procedure, in the most simplistic view, is 'the more stem cells used the better the results'. I doubt anyone knows how much is enough and if there is a 'too much'.
The human body takes the term 'complicated' to the Nth degree and too many variables to consider so it's patient heal thyself.
Perhaps the doctors have had data made available to them as part of their decision process to provide the Caverstem and Femcelz procedures.
The long term view is clearly in place in my opinion. Slow and careful and steady progress.